Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Progression of Dysarthria, Drooling, and Swallowing Disorders in Parkinson's Disease: A 1-Year Prospective Cohort Study.

American journal of speech-language pathology·2026

Same author

Disease modification in advanced Parkinson's disease: a review and roadmap for paving the way for next-generation interventions.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Same author

A Systematic Comparison of Alpha-Synuclein Seed Amplification Assays for Increasing Reproducibility.

Annals of clinical and translational neurology·2026

Same author

Neuroinflammatory profiles and cellular localization of TNF-α associated with chronic vanadium neurotoxicity.

Metabolic brain disease·2026

Same author

Neuroimaging and Pathology Biomarkers in Parkinson's Disease and Parkinsonism.

Brain sciences·2026

Same author

Uncovering the Complexity of Synucleinopathies: An Ongoing Tale Between Proteins and Lipids.

Movement disorders : official journal of the Movement Disorder Society·2025

Same journal

Nrf2 Activators in Parkinson's Disease: Modulating Mitophagy and Regulating Cuproptosis.

Molecular neurobiology·2026

Same journal

The Molecular Machinery of Synaptic Plasticity and Its Potential Role in the Aetiology of Schizophrenia.

Molecular neurobiology·2026

Same journal

Hypothalamus Amyloid Levels Are Associated with Early Sex-Dependent Alterations in Peripheral Energy Homeostasis in TgF344-AD Rats.

Molecular neurobiology·2026

Same journal

A Dose-Response Study on Human FGF21 to Inhibit Necrosis, Spectrin Breakdown, and to Increase Intracellular Cold Shock Proteins in Cultured Cortical Neurons Subjected to Oxygen-Glucose Deprivation Injury.

Molecular neurobiology·2026

Same journal

Alpha Lipoic Acid Mitigates TBI-Induced Neuroinflammation by Regulating S100B/STIM Signaling via NF-ƙB Pathway.

Molecular neurobiology·2026

Same journal

Edaravone Attenuates Retinal Ganglion Cell Ferroptosis Induced by Ischemia Reperfusion via Inhibiting the p38 MAPK/ATF3 Signaling Pathway.

Molecular neurobiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 22, 2025

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

Alpha-Synuclein Antibody Characterization: Why Semantics Matters.

Tiago Fleming Outeiro^1,2,3,4,5

¹Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center, Göttingen, Germany. touteir@gwdg.de.

Molecular Neurobiology

|January 7, 2021

Summary

This summary is machine-generated.

Toxic protein aggregates in disease are complex. Oligomeric species may be more harmful than fibrils, but identifying toxic forms requires better detection methods for protein aggregation disorders.

Keywords:

Alpha-synuclein Antibodies Neurodegeneration Oligomers Protein aggregation

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Published on: June 23, 2022

Related Experiment Videos

Last Updated: Nov 22, 2025

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Published on: June 23, 2022

Area of Science:

Neuroscience
Biochemistry
Pathology

Background:

Protein aggregation disorders involve the formation of various species like oligomers, protofibrils, and fibrils.
Evidence suggests smaller oligomeric species may be more cytotoxic than larger fibrillar forms.

Purpose of the Study:

To highlight the challenges in identifying toxic species in protein aggregation.
To emphasize the need for improved methods for characterizing protein aggregates.

Main Methods:

Review of current literature on protein aggregation and toxicity.
Discussion of limitations in existing detection and characterization techniques.
Emphasis on the need for interdisciplinary approaches.

Main Results:

The precise nature of toxic protein species remains largely undefined.
Current terminology for protein aggregates is often ambiguous and lacks standardization.
Existing methods, including antibody-based approaches, have limitations in specificity and sensitivity.

Conclusions:

Systematic and interdisciplinary studies are crucial for advancing the field.
Development of robust methods is needed to accurately detect and define toxic protein aggregates.
Clearer characterization of species is essential for understanding disease mechanisms and developing therapies.